AKE 0.00% $9.83 allkem limited

Q1 2017 (H2 2017) profit forecast, page-12

  1. 3,013 Posts.
    lightbulb Created with Sketch. 144
    Hi Niu. One of the things we have that can't be under estimated is runs on the board.
    There is no doubt recent sentiment is assisting the shorting campaign but IMO the only thing that can change this sentiment if the Fundamentals of the company.
    This could take years though given the way we produce the product.

    As far as new supply coming on line goes, will any new players have to align themselves with another company that owns the technology to extract the product?

    It appears that we have our own tech for this process?

    This enables us to expand our operations with as you say a duplicate process for expansion.

    Would it also enables us to use this technology in our new partnership or license it out?

    Could we also partner with other companies with this process?

    I get a felling that the company has just swallowed a bill pill in the latest ann.
    I am hoping we have not got any more negative news and we can get back to some more positive commentary. Sick of the shorters making all the money.Haha.
 
watchlist Created with Sketch. Add AKE (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.